Related Experiment Video
Updated: Mar 6, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Advanced oxidation protein products promote NADPH oxidase-dependent β-cell destruction and dysfunction through the
Abstract:
The accumulation of plasma advanced oxidation protein products (AOPPs) has been linked with diverse disorders, including diabetes, chronic kidney disease, obesity, and metabolic syndrome. The aim of the present study was to evaluate the pathophysiological relevance of AOPPs in β-cell destruction and dysfunction. Exposure of cultured rat β-cells (INS-1) to AOPPs induced an increase in Bax expression, caspase-3 activity, and apoptosis as well as a decrease in Bcl-2 expression in a dose- and time-dependent manner. AOPP challenge rapidly increased the production of intracellular superoxide by activation of NADPH oxidases, demonstrated by p47phox translocation and interaction with p22phox and gp91phox, and this in turn led to apoptosis. AOPPs treatment resulted in β-cell apoptosis, AOPPs accumulation, and decreased insulin content in pancreas and plasma in unilateral nephrectomized rats. Chronic inhibition of NADPH oxidase by apocynin prevented β-cell apoptosis and ameliorated insulin deficiency in AOPP-challenged rats. This study demonstrates for the first time that accumulation of AOPPs promotes NADPH oxidase-dependent β-cell destruction and dysfunction by the Bcl-2/Bax-caspase apoptotic pathway. This finding may provide a mechanistic explanation for β-cell destruction and dysfunction in patients with diverse disorders.
Insights
Accumulation of advanced oxidation protein products (AOPPs) triggers beta-cell destruction and dysfunction. This occurs via NADPH oxidase activation and the Bcl-2/Bax-caspase apoptotic pathway, potentially explaining beta-cell issues in various metabolic disorders.
Area of Science:
- Biochemistry
- Cell Biology
- Pathophysiology
Background:
- Plasma advanced oxidation protein products (AOPPs) are associated with metabolic disorders like diabetes and obesity.
- The role of AOPPs in beta-cell destruction and dysfunction remains unclear.
Purpose of the Study:
- To investigate the pathophysiological relevance of AOPPs in beta-cell destruction and dysfunction.
- To elucidate the molecular mechanisms underlying AOPP-induced beta-cell damage.
Main Methods:
- In vitro studies using cultured rat beta-cells (INS-1) exposed to AOPPs.
- In vivo studies using unilateral nephrectomized rats treated with AOPPs and apocynin.
- Assessment of apoptosis markers (Bax, Bcl-2, caspase-3 activity), NADPH oxidase activation (p47phox translocation), and insulin levels.
Main Results:
- AOPPs induced dose- and time-dependent beta-cell apoptosis by increasing Bax and caspase-3 activity while decreasing Bcl-2 expression.
- AOPP exposure activated NADPH oxidases, leading to increased intracellular superoxide production and apoptosis.
- In vivo, AOPPs caused beta-cell apoptosis, accumulation, and reduced insulin content; apocynin treatment ameliorated these effects.
Conclusions:
- AOPP accumulation promotes beta-cell destruction and dysfunction through NADPH oxidase activation and the Bcl-2/Bax-caspase apoptotic pathway.
- This mechanism offers a potential explanation for beta-cell impairment in patients with metabolic disorders associated with elevated AOPPs.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Radical Autoxidation
Bioactivation and Tissue Toxicity

